Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · GE HealthCare (GEHC)

GE HealthCare CFO Saccaro to step down; Q2 revenue up 5.7%, 2026 guidance reaffirmed

Positive Impact 4 of 5 leadership Written later

GE HealthCare said CFO Jay Saccaro will step down for a role outside the medical technology industry, with his last day on August 14, 2026, and Controller George Newcomb will serve as interim CFO. The company also reported preliminary second quarter 2026 results, with revenue up 5.7% year over year and adjusted EPS ahead of its prior expectation, and it reaffirmed full-year 2026 guidance.

Key points

  • Saccaro will leave as CFO; his last day is August 14, 2026, and the company has started a search for a permanent successor.
  • Controller and Chief Accounting Officer George Newcomb becomes interim CFO effective August 14, 2026, with no change to his compensation.
  • Preliminary Q2 2026 revenue was $5,295 million, up 5.7% year over year; organic revenue growth was 3.5%.
  • Adjusted EPS is expected to be ahead of prior expectation; full-year 2026 guidance was reaffirmed, and full Q2 results are due July 29, 2026.

The filing

CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECJul 23, 2026, 4:17 PM ET
Accession number0001932393-26-000039

Items reported: 2.02 Results of Operations5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.